|This resource center provides physicians and
healthcare professionals with a clinical overview of TDT's technology,
it to current testing models, and provides a guide for ordering
tests for patients.
Tests developed by TDT for colorectal cancer staging and post-treatment
monitoring for recurrence represent significant improvements compared
to staging by histopathology and post-treatment monitoring using
TDT tests are being introduced under on-site testing guidelines
established by federal CLIA '88 statutes.
Included in this section are: